| Literature DB >> 23503901 |
Fábio de Azevedo Caparroz1, Luciano Lobato Gregório, Eduardo Macoto Kosugi.
Abstract
UNLABELLED: Inverted papilloma (IP) has several treatment avenues. The endoscopic approach in the last decade has proven to be a good option over the traditional approach.Entities:
Mesh:
Year: 2013 PMID: 23503901 PMCID: PMC9450791 DOI: 10.5935/1808-8694.20130003
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Sample characteristics.
| Data | N | % | |
|---|---|---|---|
| Gender | Males | 14 | 82.3 |
| Females | 3 | 17.6 | |
| Side | Left | 8 | 47.0 |
| Right | 9 | 52.9 | |
| Mean | 58.76 | – | |
| SD | 7.42 | – | |
| Age (years) | Minimum | 47 | – |
| Median | 58 | – | |
| Maximum | 73 | – |
N: Number; %: percentage.
Symptom distribution.
| Symptom | N | % |
|---|---|---|
| Nasal obstruction | 17 | 100 |
| Epistaxis | 10 | 58.8 |
| Hyposmia | 9 | 52.9 |
| Anterior rhinorrhea | 7 | 41.1 |
| Headache | 6 | 35.2 |
| Cough | 4 | 23.5 |
| Posterior rhinorrhea | 2 | 11.7 |
| Cacosmia | 2 | 11.7 |
| Facial pain | 1 | 5.8 |
N: Number; %: percentage.
Comorbidities.
| Comorbidity | N | % |
|---|---|---|
| Smoking | 8 | 47.0 |
| Hypertension | 8 | 47.0 |
| Alcohol drinking | 2 | 11.7 |
| Coronary failure | 2 | 11.7 |
| Diabetes | 1 | 5.8 |
| Dyslipidemia | 1 | 5.8 |
N: Number; %: percentage.
Complications and malignization.
| Characteristics | Number | % | |
|---|---|---|---|
| Intraoperative complication | 0 | 0 | |
| Postoperative complication | Synechia | 1 | 5.8 |
| Septal perforation | 1 | 5.8 | |
| Oroantral fstula | 1 | 5.8 | |
| Malignization | 3 | 17.6 |
%: percentage.
Distribution of stages and recurrences.
| Stage | Krouse's stage | Recurrence | ||
|---|---|---|---|---|
| N | (% of cases) | N | (% of the stage) | |
| I | 0 | – | 0 | – |
| II | 5 | 29.4 | 1 | 20 |
| III | 9 | 52.9 | 2 | 22.2 |
| IV | 3 | 17.6 | 1 | 33.3 |
| Total | 17 | 100 | 4 | 23.5 |
N: Number; %: percentage.
Recurrence cases per approach and stage.
| Krouse's staging | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approach | I | II | III | IV | Total | ||||||||||
| Case | Recur | % | Case | Recur | % | Case | Recur | % | Case | Recur | % | Case | Recur | % | |
| External | – | – | – | – | – | – | 1 | 0 | 0 | 2 | 1 | 50 | 3 | 1 | 33.3 |
| Combined | – | – | – | – | – | – | 2 | 1 | 50 | 1 | 0 | 0 | 3 | 1 | 33. |
| Endoscopic | – | – | – | 5 | 1 | 20 | 6 | 1 | 16.6 | – | – | – | 11 | 2 | 18.1 |
| Total | – | – | – | 5 | 1 | 20 | 9 | 2 | 22.2 | 3 | 1 | 33.3 | 17 | 4 | 23.5 |
Recur: Recurrence; %: percentage of recurrences per approach in each group.